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Abstract
We present a 37-year-old male subject who presented with burning sensations in his hands and feet
with generalised twitching of his limbs, trunk and face. His symptoms developed 2 weeks after an
upper respiratory tract infection. There was associated facial flushing and disturbed night sleep but no
memory impairment or generalised sweating. Examination showed generalised myokymia and
fasciculations and electromyography revealed widespread continuous semi-rhythmic doublets and
triplets of low frequency with interspersed silent periods. Anti voltage gated potassium channel
antibodies, antinuclear antibodies, anti-acetylcholine receptor antibodies and the anti-neuronal
antibodies anti Hu, anti Yo and anti Ri were all negative. His symptoms improved slightly on
lamotrigine and amitriptyline.
Introduction
Neuromyotonia is a form of peripheral nerve hyperexcit-
ability with spontaneous and continuous muscle fibre
activity [1]. It has variously been called undulating
myokymia, Isaac’s syndrome and cramp-fasciculation
syndrome [2]. It might be hereditary or acquired and
there have been a variety of reported causes and
associations. Only three cases have been however been
attributed to infective causes in the literature. We present a
case of acquired neuromyotonia following an upper
respiratory tract infection and discuss the literature
relevant to the case.
Case presentation
Our patient is a 37-year-old Caucasian man who presented
with a fourteen-month history of a burning, painful sensation
in his hands and feet. This developed about two weeks after
an upper respiratory tract infection. His symptoms were
present all the time but were exacerbated by activity and
stress. There was associated twitching of his hands and face as
well as regular facial flushing and disturbed night sleep. He
had no memory impairment or sweating disturbances.
He has a past history of mild renal dysfunction and is on
antibiotics for a persistent cellulitis over his left elbow.
He does not smoke and takes only minimal alcohol.
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On examination, he had generalised myokymia and
fasciculations involving all parts of his face, tongue,
trunk and all four limbs. Power, coordination and reflexes
were normal. He had impaired pain sensation to his
ankles and wrists; other modalities of sensation were
normal.
Electromyography (EMG) revealed widespread continu-
ous semi-rhythmic doublets and triplets of low frequency
with interspersed silent periods. There were fasciculations
in the right tibialis anterior and right opponens pollicis
with some polyphasia in the tibialis anterior muscle.
Motor and sensory nerve conduction velocities were
normal. He tested negative for anti voltage gated
potassium channel (VGKC) antibodies, antinuclear anti-
bodies and anti-acetylcholine receptor antibodies. He was
also negative for the anti-neuronal antibodies anti Hu, anti
Yo and anti Ri. His creatinine kinase was mildly elevated at
474 U/L as was serum creatinine at 111-micromol/L. eGFR
was mildly reduced at 67. Computerised tomography scan
of his chest was normal.
He was initially treated with gabapentin with no benefit.
He had improvement in pain and sleep disturbance on
90 mg daily dose of amitriptyline. He also reported further
improvement in sensory symptoms on Lamotrigine but
not in motor symptoms.
Discussion
Our patient had most of the typical features of neuro-
myotonia. The major manifestations are cramps, muscle
twitching or stiffness, pseudomyotonia, paraesthesias,
numbness and hyperhydrosis [2]. The commonest feature
is muscle twitching which is present in over 90% of cases;
facial twitching is seen in a quarter of cases [1]. Our patient
had both limb and facial involvement. Central nervous
system features are seen in a quarter of cases of
neuromyotonia and these include mood change, sleep
disorders, hallucinations and personality changes [2]. Our
patient however did not report central nervous system
symptoms.
The only risk factor for neuromyotonia in our patient
appears to be the upper respiratory tract infection he had
two weeks prior to onset of symptoms. The elbow cellulitis
is unlikely to be responsible because there was no
temporal relationship to the onset of Neuromyotonia.
There have been case reports of neuromyotonia following
Staphylococcus aureus spinal epidural abscess with septicae-
mia [3,4], and there is also a report of ocular neuromyo-
tonia following cavernous sinus thrombosis due to
mucormycosis [5]. In one of these cases, antibodies to
voltage-gated potassium channels were demonstrated
during the infection, and these disappeared after
resolution of the infection [3]. Although these antibodies
were negative in our patient, they were only tested for after
he had recovered from the respiratory tract infection. It is
therefore possible that similar antibodies underlie the
pathogenesis in our patient and other cases resulting from
infective causes.
Infections are however uncommon reported causes of
neuromyotonia. More frequently reported are associations
with autoimmune diseases including myasthenia gravis,
systemic lupus erythematosus, dermatomyositis and
Hashimoto’s disease. Neuromyotonia may follow bone
marrow transplantation, radiation therapy as well as wasp
stings. It has also been reported on the background of both
acquired demyelinating [6], as well as hereditary, motor
neuropathy [7]. Associations with malignancies are with
thymoma, Hodgkin’s lymphoma and renal cell carcinoma.
Neuromyotonia is seen in anti VGKC antibody limbic
encephalitis but in only 10% of patients [8].
Our patient had the characteristic EMG features of
neuromyotonia and these are spontaneous motor unit
discharges, which are thought to originate from the distal
parts of the nerves. Typical findings are myokymic doublet
or multiplet motor discharges, the former being the more
common [2]. There is however no correlation between
abnormal findings and clinical severity of involved
muscles [2]. Subjects with abnormal EMG findings are
reportedly more likely to have anti VGKC antibodies than
those with normal EMG findings, and these antibodies are
seen in about 40% of cases of neuromyotonia [2]. Patients
with abnormal EMG features are also more likely to have
autoimmune diseases like myasthenia gravis and are more
likely to report significant disability [2]. Our patient had
elevated creatinine kinase levels and this has been reported
in half of cases of neuromyotonia [2].
The major differential diagnoses of neuromyotonia are
stiff man syndrome (in which the discharges disappear in
sleep) and motor neurone disease, in which neuromyo-
tonic discharges can be seen early on in the course [1]. Our
patient does not appear to have any of the above features.
Treatment for neuromyotonia is with anticonvulsant
agents. Phenytoin, carbamazepine, sodium valproate and
lamotrigine may be used singly or in combination [1]. It is
recommended that immunosuppression with predniso-
lone and azathioprine, or plasma exchange be considered
if these are unsuccessful [9,10]. Immunoglobulin therapy
however seems not to be helpful [1]. Our patient’s sensory
symptoms had improved with symptomatic treatment
with amitriptyline. Lamotrigine also improved his painful
symptoms but has so far not reported improvement in
muscle twitching.
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Abbreviations
eGFR, estimated glomerular filtration rate; EMG, electro-
myography; VGKC, voltage gated calcium channel.
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